Skip to content

News

OCRF Research Provides Further Evidence that Ovarian Cancer...

OCRF Research Provides Further Evidence that Ovarian Cancer Originates in Fallopian Tube

02/16/2012   Work funded by Ovarian Cancer Research Fund has shown that the high-grade serous ovarian cancer arises in the fallopian tube of mice that lack two specific genes. The report appeared online this week in the journal Proceedings of the National Academy of Sciences. Little is known about how ovarian cancer starts and spreads. Recent … Continued

Meet OCRF’s 2012 Grantees

Meet OCRF’s 2012 Grantees

OCRF has awarded $5.4 million in grants for ovarian cancer research this year. After receiving over 100 applications – the highest number in its history – OCRF and its prestigious Scientific Advisory Committee endeavored first and foremost to fund the best science. The Committee evaluated each proposal through intensive peer review, and selected a sound … Continued

Ovarian Cancer Research Fund Awards $5.4 Million in 2012 Re...

Ovarian Cancer Research Fund Awards $5.4 Million in 2012 Research Grants

OCRF receives record number of grant applications; continues to fund the best science New York, NY January 3, 2012— Ovarian Cancer Research Fund (OCRF) has awarded $5.4 million in grants for ovarian cancer research this year. After receiving over 100 applications – the highest number in its history – OCRF and its prestigious Scientific Advisory … Continued

Ovarian Cancer Research Fund Announces New Board Leadership

Ovarian Cancer Research Fund Announces New Board Leadership

John Hansbury and Sherry Jacobson elected Co-Presidents, Raynor Dahlquist and Bronwen Smith join Board of Directors New York, NY October 19, 2011— Ovarian Cancer Research Fund (OCRF) is pleased to announce the election of Co-Presidents to its Board of Directors, John W. Hansbury, Esq., and Sherry Jacobson. Hansbury and Jacobson have both served on the … Continued

Ovarian Cancer Research Fund Launches National Expansion of...

Ovarian Cancer Research Fund Launches National Expansion of Successful Support Program for Patients with Gynecologic Cancer

(New York, NY – October 4, 2011) – A unique support program that pairs women with gynecologic cancer with volunteers who have survived the disease is coming to NewYork-Presbyterian Hospital. The national Woman to Woman program, funded by Ovarian Cancer Research Fund (OCRF), was first established at The Mount Sinai Medical Center, and OCRF plans … Continued

OCRF Welcomes New Scientific Advisory Committee Members

OCRF Welcomes New Scientific Advisory Committee Members

08/09/2011 Earlier this year, OCRF welcomed two new members to its Scientific Advisory Committee: Ronny I. Drapkin, MD, PhD and Sandra Orsulic, PhD.  Both Drs. Drapkin and Orsulic are experts in ovarian cancer research, and bring valuable additional experience to our now thirteen-member Scientific Advisory Committee.  In addition, both are past recipients of OCRF grants. … Continued

Understanding Ovarian Cancer: Part One of OCRF’s Educ...

Understanding Ovarian Cancer: Part One of OCRF’s Educational Series

  09/28/2010 View a seven-part series about ovarian cancer, brought to you by the Ovarian Cancer Research Fund.The series is narrated by Douglas A. Levine, MD, of Memorial Sloan-Kettering Cancer Center.  Dr. Levine is a member of OCRF’s Scientific Advisory Committee.The video also features OCRF Board Members Carmel Cohen, MD and Robin Zarel.  

Video: Ray Ramano asks for support of ovca awareness

Video: Ray Ramano asks for support of ovca awareness

Ray Ramano supports ovarian cancer initiatives in honor of his cousin, Linda, an ovarian cancer survivor and Director of Survivors Teaching Students SM, an Ovarian Cancer National Alliance program.

Dave Bautista vs. Cancer, for Angie Bautista

Dave Bautista vs. Cancer, for Angie Bautista

Support Dave Bautista’s Mission to Cure Ovarian Cancer Every 23 minutes, another woman is diagnosed with ovarian cancer — the leading cause of gynecologic cancer death in the U.S. Despite many advances over the past decade, there is still no cure — but there is hope. Researchers are making progress against this devastating disease every … Continued

OCRF Statement on OVA1

OCRF Statement on OVA1

Some of you may have recently seen articles in the newspaper or on TV about a test called OVA1.  OVA1 is a test approved by the FDA which measures the levels of five proteins in blood samples from women with a known ovarian mass that have been reported to change when ovarian cancer is present.  … Continued

Meet OCRF's Newest Grantees

Meet OCRF's Newest Grantees

01/29/2010 Each year, OCRF awards millions of dollars in grants to researchers who are working to beat ovarian cancer.  Our two newest grantees, Dr. Lin Zhang and Dr. Kathryn Terry, each received a $200,000 renewal, which will enable them to continue their work. Lin Zhang, MD Research Assistant Professor University of Pennsylvania School of Medicine … Continued

Jeff Boyd, PhD, Appointed Chair of OCRF Scientific Advisory...

Jeff Boyd, PhD, Appointed Chair of OCRF Scientific Advisory Committee

11/17/2009 The Board of Directors of the Ovarian Cancer Research Fund (OCRF) is pleased to announce that Jeff Boyd, PhD, Chief Scientific Officer at the Fox Chase Cancer Center in Philadelphia, PA, has been appointed Chair of the OCRF Scientific Advisory Committee (SAC). The Scientific Advisory Committee is charged with evaluating research proposals to ensure … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.

Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.